These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 21903971

  • 1. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer.
    Varsavsky M, Reyes-Garcia R, Avilés Perez MD, Gonzalez Ramírez AR, Mijan JL, Muñoz-Torres M.
    J Androl; 2012; 33(4):594-600. PubMed ID: 21903971
    [Abstract] [Full Text] [Related]

  • 2. SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer.
    Varsavsky M, Reyes-García R, García-Martín A, González-Ramírez AR, Avilés-Perez MD, Muñoz-Torres M.
    Osteoporos Int; 2013 Feb; 24(2):713-9. PubMed ID: 22588185
    [Abstract] [Full Text] [Related]

  • 3. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
    Baek KH, Oh KW, Lee WY, Tae HJ, Rhee EJ, Han JH, Cha BY, Kim YJ, Lee KW, Son HY, Kang SK, Kim CC, Kang MI.
    Bone; 2006 Dec; 39(6):1352-60. PubMed ID: 16905375
    [Abstract] [Full Text] [Related]

  • 4. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A, Prenner G, Kniepeiss D, Iberer F, Tscheliessnigg KH, Piswanger-Sölkner C, Obermayer-Pietsch B, Leb G, Dobnig H.
    Wien Klin Wochenschr; 2002 Aug 30; 114(15-16):717-24. PubMed ID: 12602117
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.
    Franck H, Meurer T, Hofbauer LC.
    J Rheumatol; 2004 Nov 30; 31(11):2236-41. PubMed ID: 15517638
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status.
    Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD.
    J Clin Endocrinol Metab; 2001 Jul 30; 86(7):3162-5. PubMed ID: 11443182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study.
    Kulcsar-Jakab E, Petho Z, Pap Z, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P, Bhattoa HP.
    BMC Musculoskelet Disord; 2015 Aug 28; 16():227. PubMed ID: 26311162
    [Abstract] [Full Text] [Related]

  • 10. Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids.
    García-Fontana B, Morales-Santana S, Varsavsky M, García-Martín A, García-Salcedo JA, Reyes-García R, Muñoz-Torres M.
    Osteoporos Int; 2014 Feb 28; 25(2):645-51. PubMed ID: 23903956
    [Abstract] [Full Text] [Related]

  • 11. Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study.
    Szulc P, Hawa G, Boutroy S, Vilayphiou N, Schoppet M, Chapurlat R, Hofbauer LC.
    J Clin Endocrinol Metab; 2011 Jul 28; 96(7):2216-26. PubMed ID: 21565793
    [Abstract] [Full Text] [Related]

  • 12. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP, Scane AC, Fraser WD, Diver MJ, Eastell R, Francis RM.
    Bone; 2008 Dec 28; 43(6):999-1005. PubMed ID: 18817902
    [Abstract] [Full Text] [Related]

  • 13. Correlates of osteoprotegerin levels in women and men.
    Khosla S, Arrighi HM, Melton LJ, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL.
    Osteoporos Int; 2002 May 28; 13(5):394-9. PubMed ID: 12086350
    [Abstract] [Full Text] [Related]

  • 14. Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.
    Wang A, Karunasinghe N, Plank LD, Zhu S, Osborne S, Brown C, Bishop K, Schwass T, Tijono S, Holmes M, Masters J, Huang R, Keven C, Ferguson LR, Lawrenson R.
    Sci Rep; 2021 Jul 21; 11(1):14905. PubMed ID: 34290287
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
    Fahrleitner-Pammer A, Dobnig H, Piswanger-Soelkner C, Bonelli C, Dimai HP, Leb G, Obermayer-Pietsch B.
    Wien Klin Wochenschr; 2003 May 15; 115(9):291-7. PubMed ID: 12793029
    [Abstract] [Full Text] [Related]

  • 19. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH, Francis RM, Peaston RT, Wastell HJ.
    J Bone Miner Res; 1997 Mar 15; 12(3):472-8. PubMed ID: 9076591
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.